About
Mike has many areas of expertise but has recently focused a lot of time on the treatment of stroke and on catheter-related technologies, particularly those that reduce the incidence of nosocomial infection. Among Mike's investments are Juventas Therapeutics, Cardiox, Histosonics, Great Lakes Pharmaceuticals, and CytoPherx. Prior to joining Early Stage Partners as Managing Director in 2008, Mike held roles in sales management and corporate acquisitions for C.R. Bard Access Systems (NYSE: BCR). As Director of Corporate Development, he created the process to evaluate medical technology investments for Bard's six centralized divisions and successfully executed 14 acquisitions, licenses, and divestitures. Later, Mike managed a field sales force and negotiated multiple contracts with hospitals. Mike joined Medtronic (NYSE: MDT) in 1998 where he initially led a $750 million global product launch in cardiac rhythm management and served on product development, strategy and clinical committees
Position in the VCSift Database
- • 4 investors at Early Stage Partners are tracked.
- • 1,801 investors hold the Managing Director role in VCSift. Mike Bunker is one of them.
- • 16 investors are based in Chagrin Falls, Ohio, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Chagrin Falls, US
Contact Information
Find more investors like Mike
Search Investors